Furthermore, our data suggested that progenitor-specific reduction in pro-BDNF expression would be a promising strategy to prevent and treat chronic disorders related to adipose tissue aging, such as type II diabetes. This evidence concerns the gene BDNF and type 2 diabetes mellitus.